Clinical review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy
The objective of this review was to perform a systematic review of the beneficial and harmful effects of iron isomaltoside 1000 injection (100 mg elemental iron/ml) for the treatment of iron deficiency anemia in adults (greater than/equal to 18 years of age) who have an intolerance or unresponsivene...
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
2020, May 2020
|
Edition: | Final |
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this review was to perform a systematic review of the beneficial and harmful effects of iron isomaltoside 1000 injection (100 mg elemental iron/ml) for the treatment of iron deficiency anemia in adults (greater than/equal to 18 years of age) who have an intolerance or unresponsiveness to oral iron |
---|---|
Physical Description: | 1 PDF file (99 pages) illustrations |